Distek Awarded U.S. Patent 8,903,673
News Feb 24, 2015
Distek, Inc. has been awarded U.S. Patent 8,903,673 for their modularity design and the individual position software control.
Distek’s patented, self-contained, modularity design is configurable for up to 8 positions when in use on the symphony 7100 “Bathless” Dissolution Instrument and 6 positions when in use on thesensIR 3200 “Bathless” Disintegrator. This modularity design allows users unprecedented ease and scalability.
“Distek is excited to have been awarded this patent which exemplifies our commitment to providing technically innovative products offering valuable feature benefits to our customer base,” says Jeff Brinker, President, Distek, Inc.
Brinker continued, “This patent in particular allows our customers a great deal of flexibility in the symphony 7100 and sensIR 3200 platforms in its modularity both mechanically as well as in the user interface design.”
University of Texas at Dallas scientists have demonstrated that the growth rate of the majority of lung cancer cells relates directly to the availability of a crucial oxygen-metabolizing molecule. Researchers have engineered and extensively characterized new molecules aimed at starving the cancer cells of the molecule that allows them to proliferate so quickly.